In the current study, different doses of TFENF were found to promote alveolar fluid transport by regulating AQP-1, AQP-5, αENaC, βENaC, and Na+-K+-ATPase to reduce pulmonary edema. The gene discussed is AQP1; the disease is pulmonary edema.